Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales18.7618.37 2 OPM %5.605.44 - PBDT1.030.99 4 PBT0.860.80 8 NP0.980.56 75 Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Net profit of Sandu Pharmaceuticals rose 4.00% to Rs 0.52 crore in the quarter ended September 2025 as against Rs 0.50 crore during the previous quarter ended September 2024. Sales declined 0.45% to Rs 17.62 crore in the quarter ended September 2025 as against Rs 17.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales17.6217.70 0 OPM %4.885.14 - PBDT0.880.91 -3 PBT0.710.74 -4 NP0.520.50 4 Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 October 2025.Powered by Capital Market - Live News